These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38634664)

  • 1. Pharmacological characterization of allosteric modulators: A case for chemokine receptors.
    den Hollander LS; IJzerman AP; Heitman LH
    Med Res Rev; 2024 Apr; ():. PubMed ID: 38634664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches for probing allosteric interactions at 7 transmembrane spanning receptors.
    Klein MT; Vinson PN; Niswender CM
    Prog Mol Biol Transl Sci; 2013; 115():1-59. PubMed ID: 23415091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Pharmacology of Chemokine Receptors.
    de Wit RH; de Munnik SM; Leurs R; Vischer HF; Smit MJ
    Methods Enzymol; 2016; 570():457-515. PubMed ID: 26921959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric modulators of G-protein-coupled receptors.
    May LT; Christopoulos A
    Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Modulators of Dopamine D
    Kaczor AA; Wróbel TM; Bartuzi D
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of G protein-coupled receptors.
    May LT; Leach K; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
    Müller CE; Schiedel AC; Baqi Y
    Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulation of G protein-coupled receptors.
    May LT; Avlani VA; Sexton PM; Christopoulos A
    Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of [3H]VUF11211, a novel radiolabeled small-molecule inverse agonist for the chemokine receptor CXCR3.
    Scholten DJ; Wijtmans M; van Senten JR; Custers H; Stunnenberg A; de Esch IJ; Smit MJ; Leurs R
    Mol Pharmacol; 2015 Apr; 87(4):639-48. PubMed ID: 25576486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Molecular switches" on mGluR allosteric ligands that modulate modes of pharmacology.
    Wood MR; Hopkins CR; Brogan JT; Conn PJ; Lindsley CW
    Biochemistry; 2011 Apr; 50(13):2403-10. PubMed ID: 21341760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
    Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
    Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulators targeting CNS muscarinic receptors.
    Bock A; Schrage R; Mohr K
    Neuropharmacology; 2018 Jul; 136(Pt C):427-437. PubMed ID: 28935216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.
    Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH
    Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulation of G-protein coupled receptors.
    Jensen AA; Spalding TA
    Eur J Pharm Sci; 2004 Mar; 21(4):407-20. PubMed ID: 14998571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of fluorescent peptide G protein-coupled receptor activation biosensors for NanoBRET characterization of intracellular allosteric modulators.
    Farmer JP; Mistry SN; Laughton CA; Holliday ND
    FASEB J; 2022 Nov; 36(11):e22576. PubMed ID: 36183332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Application of Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the CXC Chemokine Receptor 2.
    Casella BM; Farmer JP; Nesheva DN; Williams HEL; Charlton SJ; Holliday ND; Laughton CA; Mistry SN
    J Med Chem; 2023 Sep; 66(18):12911-12930. PubMed ID: 37523859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.